ArticleNeuropsychiatric disease and treatment2018

Factors impacting the efficacy of venlafaxine extended release 75-225 mg/day in patients with major depressive disorder: exploratory post hoc subgroup analyses of a randomized, double-blind, placebo-controlled study in Japan.

Yoshinori Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.